An intervention to decrease catheter-related bloodstream infections in the ICU
Peter Pronovost, Dale Needham, Sean Berenholtz, David Sinopoli, Haitao Chu, Sara Cosgrove, Bryan Sexton, Robert Hyzy, Robert Welsh, Gary Roth, Joseph Bander, John Kepros, Christine Goeschel, Peter Pronovost, Dale Needham, Sean Berenholtz, David Sinopoli, Haitao Chu, Sara Cosgrove, Bryan Sexton, Robert Hyzy, Robert Welsh, Gary Roth, Joseph Bander, John Kepros, Christine Goeschel
Abstract
Background: Catheter-related bloodstream infections occurring in the intensive care unit (ICU) are common, costly, and potentially lethal.
Methods: We conducted a collaborative cohort study predominantly in ICUs in Michigan. An evidence-based intervention was used to reduce the incidence of catheter-related bloodstream infections. Multilevel Poisson regression modeling was used to compare infection rates before, during, and up to 18 months after implementation of the study intervention. Rates of infection per 1000 catheter-days were measured at 3-month intervals, according to the guidelines of the National Nosocomial Infections Surveillance System.
Results: A total of 108 ICUs agreed to participate in the study, and 103 reported data. The analysis included 1981 ICU-months of data and 375,757 catheter-days. The median rate of catheter-related bloodstream infection per 1000 catheter-days decreased from 2.7 infections at baseline to 0 at 3 months after implementation of the study intervention (P< or =0.002), and the mean rate per 1000 catheter-days decreased from 7.7 at baseline to 1.4 at 16 to 18 months of follow-up (P<0.002). The regression model showed a significant decrease in infection rates from baseline, with incidence-rate ratios continuously decreasing from 0.62 (95% confidence interval [CI], 0.47 to 0.81) at 0 to 3 months after implementation of the intervention to 0.34 (95% CI, 0.23 to 0.50) at 16 to 18 months.
Conclusions: An evidence-based intervention resulted in a large and sustained reduction (up to 66%) in rates of catheter-related bloodstream infection that was maintained throughout the 18-month study period.
Copyright 2006 Massachusetts Medical Society.
Source: PubMed
今後の臨床試験
-
Magnus MedicalCongressionally Directed Medical Research Programs募集
-
Nicholas ButowskiSiren Biotechnologyまだ募集していません神経膠腫 | 脳腫瘍 | 再発性の高悪性度神経膠腫アメリカ
-
State University of New York at Buffaloまだ募集していません
-
Poitiers University Hospitalまだ募集していません
-
Assistance Publique - Hôpitaux de Parisまだ募集していません
-
University of California, Irvine募集脳腫瘍 | 中枢神経系がん | 神経系がん | 脳癌転移性アメリカ
-
Guangdong Raynovent Biotech Co., Ltdまだ募集していません
-
The Hong Kong Polytechnic UniversityWu Jieh Yee Charitable Foundation募集
-
Shanghai General Hospital, Shanghai Jiao Tong University...まだ募集していません
-
Sun Yat-sen Universityまだ募集していません禁煙 | AIエージェント | Early-Stage Cancer
-
Affiliated Hospital of Nantong Universityまだ募集していません